Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cauda equina arachnoiditis - a rare manifestation of West Nile virus neuroinvasive disease: A case report.
Santini M, Zupetic I, Viskovic K, Krznaric J, Kutlesa M, Krajinovic V, Polak VL, Savic V, Tabain I, Barbic L, Bogdanic M, Stevanovic V, Mrzljak A, Vilibic-Cavlek T. Santini M, et al. Among authors: krajinovic v. World J Clin Cases. 2020 Sep 6;8(17):3797-3803. doi: 10.12998/wjcc.v8.i17.3797. World J Clin Cases. 2020. PMID: 32953855 Free PMC article.
Severe West Nile Virus Neuroinvasive Disease: Clinical Characteristics, Short- and Long-Term Outcomes.
Santini M, Haberle S, Židovec-Lepej S, Savić V, Kusulja M, Papić N, Višković K, Župetić I, Savini G, Barbić L, Tabain I, Kutleša M, Krajinović V, Potočnik-Hunjadi T, Dvorski E, Butigan T, Kolaric-Sviben G, Stevanović V, Gorenec L, Grgić I, Glavač F, Mehmedović A, Listeš E, Vilibić-Čavlek T. Santini M, et al. Among authors: krajinovic v. Pathogens. 2022 Jan 2;11(1):52. doi: 10.3390/pathogens11010052. Pathogens. 2022. PMID: 35056000 Free PMC article.
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
REMAP-CAP Writing Committee for the REMAP-CAP Investigators; Bradbury CA, Lawler PR, Stanworth SJ, McVerry BJ, McQuilten Z, Higgins AM, Mouncey PR, Al-Beidh F, Rowan KM, Berry LR, Lorenzi E, Zarychanski R, Arabi YM, Annane D, Beane A, van Bentum-Puijk W, Bhimani Z, Bihari S, Bonten MJM, Brunkhorst FM, Buzgau A, Buxton M, Carrier M, Cheng AC, Cove M, Detry MA, Estcourt LJ, Fitzgerald M, Girard TD, Goligher EC, Goossens H, Haniffa R, Hills T, Huang DT, Horvat CM, Hunt BJ, Ichihara N, Lamontagne F, Leavis HL, Linstrum KM, Litton E, Marshall JC, McAuley DF, McGlothlin A, McGuinness SP, Middeldorp S, Montgomery SK, Morpeth SC, Murthy S, Neal MD, Nichol AD, Parke RL, Parker JC, Reyes LF, Saito H, Santos MS, Saunders CT, Serpa-Neto A, Seymour CW, Shankar-Hari M, Singh V, Tolppa T, Turgeon AF, Turner AM, van de Veerdonk FL, Green C, Lewis RJ, Angus DC, McArthur CJ, Berry S, Derde LPG, Webb SA, Gordon AC. REMAP-CAP Writing Committee for the REMAP-CAP Investigators, et al. JAMA. 2022 Apr 5;327(13):1247-1259. doi: 10.1001/jama.2022.2910. JAMA. 2022. PMID: 35315874 Free PMC article. Clinical Trial.
48 results